Read More

EXLUSIVE: SAB Biotherapeutics To Raise Up To $130M Via Preferred Equity To Advance Development Of Lead Diabetes Candidate

SAB Biotherapeutics (NASDAQ: SABS) has entered into a securities purchase agreement with certain investors to issue and sell shares of preferred stock in a private placement of up to $130 million in gross proceeds.

SABS

Read More

EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations

ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. ProSomnus's Executive Chair, CEO, and CFO are also participating in the financing.

OSA

Read More

EXCLUSIVE: Truck Cover Player Worksport Signs Long Term Pact With US Customer, Expects $16M Annual Sales

Worksport Ltd (NASDAQ: WKSP) has secured a long-term supply agreement with an undisclosed automotive aftermarket reseller in the U.S.  Worksport manufactures tonneau covers for light truck models. The company offers specialized covers with solar charging for electric trucks.

WKSP